The 3M Company, originally incorporated as the Minnesota Mining and Manufacturing Company, is an American multinational conglomerate, incorporated in the State of Delaware since 1929 (I.R.S. Employer Identification No. 41-0417775), engaged in manufacturing and technology development across sectors including industrial abrasives, adhesives, safety equipment, consumer products, and electronics. Founded on February 14, 1902, in Two Harbors, Minnesota, by five investors seeking to mine corundum for abrasives, the venture pivoted to manufacturing sandpaper after mineral deposits proved inadequate, marking the onset of its diversification into innovative materials and applications. Headquartered in Maplewood, Minnesota, since the 1960s, 3M operates globally with products sold in over 200 countries.^[1][2] 3M's hallmark is its emphasis on applied research and employee-driven innovation, exemplified by the "15% rule" permitting workers to allocate time to self-directed projects, which has yielded breakthroughs like masking tape, Scotchgard fabric protector, and Post-it Notes. The company has amassed over 69,000 patents worldwide, with approximately 3,000 issued annually, underscoring its sustained technological leadership. In fiscal year 2024, 3M generated $24.6 billion in net sales, reflecting resilience amid strategic shifts such as the 2023 spin-off of its healthcare division into the independent Solventum Corporation to streamline focus on core industrial and consumer segments.^[1][3][4][5] Notwithstanding these accomplishments, 3M has encountered substantial legal and environmental liabilities, including a $6 billion settlement in 2023 resolving multidistrict litigation over defective Combat Arms earplugs supplied to the U.S. military, which allegedly failed to prevent hearing loss and tinnitus among service members due to improper fitting instructions and design flaws. Separately, in 2023, the company agreed to a $12.5 billion payout to address per- and polyfluoroalkyl substances (PFAS) contamination in drinking water from its aqueous film-forming foam manufacturing, acknowledging the persistent environmental impact of these "forever chemicals" despite ongoing debates over regulatory standards and causation in health effects. These resolutions, totaling over $18 billion in commitments, have strained finances and prompted operational adjustments, including workforce reductions and debt management.^[6][7][4]

History

Founding and Early Challenges (1902–1930s)

The Minnesota Mining and Manufacturing Company (later known as 3M) was founded on February 14, 1902, in Two Harbors, Minnesota, by five local businessmen: Henry S. Bryan, Dr. J. Danley Budd, Hermon W. Cable, John Dwan, and William A. McGonagle.^[1][8] The venture aimed to extract corundum, a hard mineral essential for producing abrasives like sandpaper and grinding wheels, capitalizing on deposits believed to exist in the region.^[1] Initial operations involved rudimentary mining with hand tools and horse-drawn equipment, but assays conducted shortly after startup revealed the ore was anorthosite—a low-value feldspar unsuitable for commercial abrasives—prompting an immediate pivot to manufacturing sandpaper from imported minerals.^[2][9] In 1929, to continue operations begun in 1902, the company was reincorporated under the laws of the State of Delaware as the Minnesota Mining and Manufacturing Company (later renamed 3M Company), with principal executive offices at 3M Center, St. Paul, Minnesota 55144-1000 (serving the Maplewood headquarters location). Early years were marked by severe financial distress, with the company nearly collapsing due to the failed mining premise, inadequate capital, and inefficient production methods.^[10] By 1905, persistent losses threatened bankruptcy, but investment from St. Paul businessman Lucius P. Ordway—initially $12,000 in exchange for a controlling interest—provided stabilization and enabled a shift toward abrasives manufacturing.^[9] Ordway's funding supported experiments with garnet-based sandpaper, leading to the company's first commercial product, Three-M-ite, introduced around 1907, though sales remained limited amid competition from established firms like Norton Abrasives.^[2][9] In 1910, to access better transportation, labor, and markets, the company relocated its headquarters and primary operations to St. Paul, Minnesota, establishing a small factory that marked the beginning of urban expansion.^[11] Despite this, challenges persisted through the 1910s, including inconsistent quality control, supply chain disruptions, and economic pressures from World War I, which strained raw material imports; the firm achieved its first profitable year only in 1916.^[11][9] Innovations during this period, such as the development of waterproof sandpaper (Wetordry) in 1921 by employee Francis Gloyd, addressed automobile manufacturing demands for smoother finishes but required ongoing refinements to overcome adhesion and durability issues.^[11] The 1920s brought further hurdles, including a 1921 recession that halved sales and intensified internal debates over diversification versus core abrasives focus.^[2] Salesman Richard G. Drew's invention of masking tape in 1925—born from customer complaints about existing adhesives damaging auto paint—provided a breakthrough, generating initial revenue of $32 in its first order and laying groundwork for adhesive products, though scaling production involved trial-and-error with crepe paper backings and rubber-based glues.^[11][9] By the late 1920s, employee growth to around 1,000 and tape innovations signaled stabilization, yet the company's survival hinged on Ordway's continued infusions and a cultural emphasis on technical problem-solving amid skepticism from investors doubting the shift from mining.^[1][12]

Mid-Century Expansion and Innovation (1940s–1970s)

During World War II, 3M shifted production to support the war effort, developing over 100 variants of Scotch tapes, Scotchlite reflective materials for markings, Safety-Walk non-slip surfaces, and specialized abrasives and adhesives for military applications, including aircraft repairs.^[13][14] The company's workforce expanded dramatically from 3,133 employees in July 1941 to 7,046 by August 1945, incorporating women as lab assistants starting in 1942 and older men to replace those serving in the armed forces, with over 2,000 employees enlisting.^[15] Factories operated around the clock in three 8-hour shifts under federal wartime regulations, enabling production of materials like magnetic sound recording tape and items for military aircraft.^[16][15] Postwar recovery fueled rapid expansion, with sales exceeding $100 million by 1949 and employment reaching 10,000 workers.^[2] In 1946, 3M's stock was listed on the New York Stock Exchange, providing capital for growth.^[1] Key innovations included the 1947 introduction of Scotch magnetic audiotape, which advanced sound recording technology, and the establishment of a policy in 1948 allowing employees to dedicate 15% of their time to independent projects, fostering internal innovation.^[2][16] The 1950s marked significant international expansion, with the creation of an International Division in 1951 leading to the formation of subsidiaries in Australia, Brazil, Canada, France, Germany, Mexico, and the United Kingdom.^[1] Product innovations included the Thermo-Fax dry-printing photocopy process in 1951 and Scotchgard fabric protector in 1956, alongside the late-decade launch of the first metered-dose asthma inhaler.^[2][16] In the 1960s, 3M doubled in size between 1963 and 1967, achieving billion-dollar annual sales and diversifying into microfilm, overhead projection systems, dry-silver microfilm, photographic products, carbonless papers, and medical items like Micropore hypoallergenic surgical tape introduced in 1960.^[2][16][1] International presence grew with subsidiaries in Japan (as Sumitomo 3M) and Puerto Rico in 1960, followed by Austria, Colombia, Denmark, and Hong Kong in 1961.^[17] The company completed its global headquarters at 3M Center in Maplewood, Minnesota, in 1962, and its products supported NASA's Apollo 11 moon landing in 1969.^[1] The 1970s saw continued diversification into pharmaceuticals and radiology equipment, though growth moderated amid economic challenges.^[16] In 1976, 3M joined the Dow Jones Industrial Average, reflecting its stature as a diversified industrial leader.^[2][16]

Late 20th Century Globalization (1980s–2000)

During the 1980s, 3M intensified its globalization efforts amid declining trade barriers and the emergence of regional economic blocs such as the European Union and the North American Free Trade Agreement, shifting from decentralized local operations to more coordinated worldwide product strategies through collaboration between U.S. executives and international division managers.^[18] This integration facilitated standardized offerings across markets while adapting to regional needs, building on 3M's established presence in over 40 countries. A pivotal milestone occurred in 1984 when 3M became the first wholly foreign-owned enterprise approved in the People's Republic of China, establishing manufacturing and sales operations that laid the foundation for rapid expansion in Asia.^[11] By the early 1990s, international sales surpassed domestic revenue for the first time, accounting for more than 50 percent of total sales in 1992, driven by growth in the Asia-Pacific region and Europe.^[9] This shift reflected 3M's strategy of local-for-local adaptation evolving into global scale efficiencies, with operations spanning over 200 countries by the mid-1990s and foreign markets contributing 52 percent of the company's $15.1 billion in total sales by 1997.^[19] Expansion included new facilities, such as the granule manufacturing plant in Pittsboro, North Carolina, opened in the early 1980s to serve southeastern U.S. and export markets, alongside investments in Asia (including Korea and China) and Eastern Europe to capitalize on emerging demand for industrial and consumer products.^[20] Throughout the 1990s, 3M sustained globalization through innovation-driven exports and localized production, with over 30 percent of 1990 sales derived from products introduced within the prior four years, many tailored for international applications in sectors like electronics and healthcare.^[21] The company's international division emphasized self-funding via local borrowing, fostering resilience but also tying growth to regional economic conditions. By 2000, this approach had positioned 3M as a diversified multinational, with global operations generating sustained revenue growth despite periodic slowdowns in mature markets.^[9]

21st Century Transformations and Spin-offs (2001–Present)

In the early 2000s, 3M undertook significant restructuring in response to economic pressures, including a slowdown following the dot-com bust and broader recessionary conditions. In April 2001, the company announced plans to eliminate approximately 5,000 positions worldwide, representing about 6% of its workforce, to address declining profits and streamline operations without discontinuing major product lines.^[22] By September 2002, 3M reorganized its structure into seven business units from existing divisions, aiming to enhance leadership focus and operational efficiency amid a 3% share price drop on the announcement day.^[23] These moves generated restructuring charges but preserved core innovation-driven growth, with further refinements in 2009 yielding nearly $400 million in annual savings through business realignments.^[24] Throughout the 2010s, 3M continued portfolio adjustments via acquisitions and selective divestitures, acquiring 77 companies since 2001 to bolster capabilities in high-growth areas, while merging underperforming units.^[25] In February 2013, it cut 300 jobs by combining its securities systems and traffic safety systems divisions to eliminate redundancies.^[26] By January 2015, the company consolidated from six to five major divisions, introducing new executive roles to sharpen strategic alignment and market responsiveness.^[27] These efforts supported sustained revenue expansion but were punctuated by ongoing cost controls amid cyclical industrial demand. The 2020s marked accelerated transformations, driven by legal liabilities, market shifts, and a strategic pivot to core material science competencies. In April 2023, 3M initiated a global restructuring, eliminating 6,000 positions (about 8% of its workforce) to counter weak first-quarter performance and optimize for long-term profitability.^[28] This coincided with divestitures, including the September 2022 separation of its food safety business via merger with Neogen Corporation in a $3.7 billion deal, allowing 3M to exit a lower-margin segment.^[29] The capstone was the July 2022 announcement to spin off its healthcare unit—encompassing wound care, oral care, and health informatics—into an independent entity to unlock value and refocus 3M on industrials, safety, and consumer segments.^[30] Named Solventum and revealed in November 2023, the business completed its tax-free spin-off on April 1, 2024, trading on the NYSE under "SOLV," with 3M initially retaining a 19.9% stake before full divestiture plans.^[31][32] The transaction transferred $2.5 billion in pension obligations to Solventum and prompted a 53.6% dividend cut to fund debt reduction and litigation resolutions, including a $10.3 billion settlement for PFAS contamination claims finalized concurrently.^[33][34] Under new CEO William Brown, appointed in May 2024, 3M has pursued further portfolio pruning, with October 2025 reports indicating explorations of billions in divestitures from low-growth industrial assets to enhance margins and accelerate a turnaround emphasizing operational efficiency and innovation in adhesives, abrasives, and electronics.^[35][36] These changes have yielded sequential profit improvements, with adjusted earnings per share rising to $2.19 in Q3 2025, though legacy liabilities continue to shape capital allocation priorities.^[37]

Business Operations

Core Divisions and Product Categories

3M operates in a competitive industrials sector, with top direct competitors including Honeywell International Inc. (HON), Danaher Corporation (DHR), Illinois Tool Works Inc. (ITW), Emerson Electric Co. (EMR), ITT Inc. (ITT), Carlisle Companies Inc. (CSL), and Griffon Corporation (GFF).^[38][39] Following the spin-off of its Health Care business into Solventum effective April 1, 2024, 3M structures its operations around three core business segments: Safety and Industrial, Transportation and Electronics, and Consumer.^[40] These segments encompass thousands of products derived from 3M's materials science expertise, serving industrial, transportation, electronics, and consumer markets globally.^[41] In 2024, the segments collectively generated $24.6 billion in net sales, with Safety and Industrial comprising the largest share at 44.6%.^[40] The Safety and Industrial segment delivers personal protective equipment, abrasives, adhesives, tapes, and specialty materials to enhance worker safety, industrial efficiency, and automation across sectors like manufacturing, automotive aftermarket, electrical, and roofing.^[40] Key product categories include:

• Personal safety items such as disposable respirators, hearing protection, eye protection, and fall protection harnesses.
• Abrasives like 3M™ Cubitron™ II for precision grinding and finishing.
• Industrial adhesives and tapes for bonding and sealing in robotics and automation.
• Roofing granules and masking systems for construction and packaging applications.

This segment recorded $10.961 billion in 2024 net sales, with flat overall growth offset by productivity gains that boosted operating margins by 7.2 percentage points.^[40] The Transportation and Electronics segment supplies advanced materials, films, and components for automotive electrification, aerospace, semiconductors, data centers, and commercial signage, addressing needs in display enhancement, thermal management, and structural integrity.^[40] Principal product categories feature:

• Electronics solutions including circuit materials, chip packaging, light management films, and data center cooling technologies.
• Automotive and aerospace components such as ceramic solutions for sound and temperature control.
• Commercial branding products like reflective graphic films (e.g., Scotchlite™) and architectural finishes (e.g., 3M™ DI-NOC™).

Net sales reached $8.380 billion in 2024, down 1.4% year-over-year but with adjusted growth of 3.1% excluding per- and polyfluoroalkyl substances (PFAS)-related impacts, alongside a 20.2 percentage point rise in operating margins from cost efficiencies.^[40] The Consumer segment provides branded consumer goods for home care, office productivity, safety, and packaging, emphasizing durable, user-friendly solutions in retail channels.^[40] Core categories consist of:

• Home and auto care items like cleaning products, automotive appearance restorers, and air filtration systems (e.g., Filtrete™).
• Office and stationery products including Scotch™ tapes, Post-it® notes, and Scotchgard™ fabric protectors.
• Safety and well-being aids such as bandages, braces, and picture hanging hardware (e.g., Command™ hooks).
• Home improvement tools like retail abrasives and paints.

This segment achieved $4.931 billion in 2024 net sales, reflecting a 1.9% decline due to reduced discretionary spending, though operating margins improved by 3.1 percentage points via operational enhancements.^[40]

Research and Development Strategy

3M's research and development (R&D) strategy emphasizes sustained investment in materials science and cross-divisional innovation to drive product diversification across its business units. In 2024, the company allocated $1.1 billion to R&D, equivalent to 4.4% of sales, supporting advancements in over 49 technology platforms ranging from adhesives and abrasives to ceramics and nanotechnology.^{[42] [43]} This approach has yielded more than 135,000 patents historically, underscoring a focus on proprietary technologies that enable incremental improvements and disruptive breakthroughs.^[42] Central to 3M's innovation culture is the "15% rule," instituted over 70 years ago, which permits technical employees to dedicate up to 15% of their work time to self-directed projects aligned with business objectives.^[44] This policy fosters employee autonomy and has directly contributed to iconic products, such as Post-it Notes, by encouraging experimentation outside routine assignments.^[45] Complementing this, 3M promotes open innovation through collaborations with external partners, integrating diverse expertise to accelerate development cycles and address market needs in areas like sustainability and energy resilience.^[46] In recent years, 3M has reorganized its R&D operations to decentralize decision-making, embedding research closer to business divisions while maintaining centralized oversight for technology platforms.^[47] This shift, implemented around 2022, aims to enhance responsiveness to customer demands, including sustainability targets such as reducing virgin fossil-based plastics by 125 million pounds by 2025.^[48] Looking ahead, the company plans to invest $3.5 billion in R&D from 2025 to 2027, prioritizing artificial intelligence integration for materials discovery and operational efficiency, with a goal of launching 1,000 new products over this period.^[49] These efforts include reallocating capital expenditures toward R&D facility upgrades to support faster iteration and commercialization.^[50]

Patent Portfolio and Intellectual Property

3M maintains one of the largest intellectual property portfolios among industrial conglomerates, with a total of 69,622 patents globally as of 2024, of which 36,373 have been granted and over 43% remain active.^[3] This extensive holdings span key technology areas including adhesives, abrasives, healthcare products, electronics, and safety equipment, reflecting the company's diversified operations. In the United States, 3M Innovative Properties Company, a subsidiary established to centralize IP management, received 398 patents in 2024, ranking it among the top recipients.^[51] Over the preceding years, 3M's scientists secured an average of 3,500 patents annually, underscoring a sustained commitment to innovation as a core business driver.^[52] The company's intellectual property strategy emphasizes proactive filing, licensing, and enforcement to protect technological advantages and generate revenue. 3M relies on patents alongside trademarks and trade secrets to safeguard its market position, with IP rights explicitly identified as critical assets in regulatory disclosures.^[53] Through 3M Innovative Properties, the firm manages cross-licensing agreements, as demonstrated in arrangements with affiliates and spin-offs, ensuring continuity of IP access post-restructuring.^[54] Trademarks for iconic brands such as Scotch, Post-it, and Filtrete further bolster this portfolio, with usage governed by dedicated agreements to maintain brand integrity.^[55] Enforcement efforts include litigation to defend against infringement, though outcomes vary. For instance, 3M settled a European patent dispute with Saint-Gobain Abrasives over paint preparation technologies, while facing invalidation of an abrasive particles patent in the UK High Court on grounds of undue burden.^[56][57] More recently, 3M has been accused of infringing patents related to wound treatment products in U.S. federal court.^[58] Strategic acquisitions, such as the 2023 transfer of 548 U.S. patents from KCI Licensing, have expanded the portfolio in medical technologies ahead of full business integration.^[59] Overall, 3M's IP framework supports long-term competitiveness by converting research outputs into proprietary assets, with patents viewed not merely as legal protections but as embodiments of enduring innovation.^[60]

Financial Performance

Revenue Growth and Key Metrics

3M's revenue experienced robust long-term growth driven by diversification into adhesives, consumer products, and industrial materials following its initial focus on mining abrasives in the early 1900s. By the mid-20th century, annual sales exceeded $100 million, accelerating to billions amid post-World War II demand for innovations like magnetic tapes and reflective materials. Revenue compounded at an average annual rate of approximately 8-10% from the 1950s through the 1990s, fueled by global expansion and R&D investments yielding high-margin products.^[61][62] In recent decades, revenue peaked at $34.2 billion in 2022 but declined to $32.7 billion in 2023 and $24.6 billion in 2024 following the April 2024 spin-off of the health care business as Solventum, which removed approximately $8.2 billion in annual sales from 3M's consolidated figures. This restructuring aimed to streamline operations amid legal settlements for PFAS chemicals and combat earplugs, prioritizing higher-margin segments like safety and industrial. Post-spin-off, organic sales growth turned positive, with adjusted organic sales up 1.2% year-over-year for full-year 2024.^[62][4][63] Key metrics for 2024 included gross margins of around 47%, operating margins of 19.8% (adjusted), and EBITDA of approximately $6.2 billion, reflecting cost discipline despite litigation charges exceeding $10 billion in reserves. Trailing twelve months revenue as of September 30, 2025, reached $24.8 billion, with quarterly revenue growth of 3.5% in Q3 2025 to $6.52 billion, driven by 3.2% organic growth in core divisions. For 2025, 3M projects adjusted organic sales growth of up to 3%, with adjusted EPS guidance raised to $7.95-$8.05, signaling margin expansion to 24-25% through efficiency gains.^{[64][62][63][37]}

Recent Earnings and Stock Performance

In the third quarter of 2025, ending September 30, 3M reported GAAP net sales of $6.5 billion, a 3.5% increase year-over-year, driven by organic growth of 3.2% across all business groups.^{[63] [65]} The company's GAAP operating margin expanded to 22.2%, up 130 basis points from the prior year, while adjusted operating margin reached 24.7%, reflecting a 170 basis point improvement.^{[63] [66]} GAAP diluted earnings per share (EPS) stood at $1.55, down 38% year-over-year due to certain charges, but adjusted EPS rose to $2.19, a 10% increase, marking the fourth consecutive quarter of positive organic sales growth.^{[63] [67]} Operating cash flow reached $1.8 billion for the quarter.^[63] Following the Q3 results, released on October 21, 2025, 3M raised its full-year 2025 guidance, projecting adjusted EPS of $7.95 to $8.05, up from prior estimates, amid ongoing margin expansion efforts and cost discipline.^{[63] [37]} This performance reflects stabilization post-restructuring, including the prior spin-off of its healthcare business, with trailing twelve-month revenue at $24.6 billion.^{[67] [68]} 3M's stock (NYSE: MMM) surged in response to the Q3 earnings, climbing 10.4% in the immediate aftermath and reaching an all-time high closing price of $171.60 on October 23, 2025.^{[69] [70]} Over the five days ending October 24, 2025, shares gained 10.39%, with a one-month increase of 10.27%, though year-to-date performance through late October remained tempered by earlier legal and operational headwinds.^[71] The stock closed at $168.50 on October 24, 2025, amid elevated trading volume.^[72] Analysts noted the rally as tied to sustained organic growth and profitability gains, despite ongoing litigation risks.^[73]

Spin-offs and Restructuring Impacts

In 1996, 3M spun off its data storage and imaging divisions into Imation Corporation, effective July 1, which accounted for approximately 20% of 3M's sales, employees, and product lines at the time, valued at around $2.3 billion.^[74][75] This divestiture allowed 3M to streamline its portfolio by separating maturing magnetic media and imaging businesses from its core innovation-driven segments, though Imation later faced market challenges in data storage.^[76] The most significant recent spin-off occurred on April 1, 2024, when 3M separated its Health Care business into Solventum Corporation, distributing 80.1% of Solventum shares to 3M shareholders on a one-for-four basis, while retaining 19.9% for monetization within five years.^[32][77] The transaction was structured as tax-free for U.S. federal income tax purposes, enabling Solventum to operate independently with a focus on medical-surgical products and health information systems, while allowing 3M to concentrate on industrial, safety, and consumer segments.^[78] Financially, the spin-off reduced 3M's revenue base by the healthcare unit's contribution—previously about 20% of total sales—but improved operational focus and capital allocation efficiency, though it introduced higher interest expenses from associated debt and increased working capital needs.^[79][80] In response, 3M reduced its quarterly dividend by 53.6% to $0.70 per share starting June 12, 2024, to preserve cash amid post-spin-off adjustments and litigation resolutions.^[33] Concurrently, 3M undertook major restructurings in 2023 to address declining demand in consumer electronics and manufacturing slowdowns, including 2,500 manufacturing job cuts in January and an additional 6,000 global positions in April, totaling about 8,500 layoffs or roughly 10% of its workforce.^[81][82] These actions, combined with facility consolidations, targeted annual pre-tax savings of $700 million to $900 million, with full realization expected by 2025, contributing to margin expansion and free cash flow generation.^[83][84] Overall, these initiatives led to a 0.1% annual sales decline in 2024 (adjusted for divestitures), but positioned 3M for up to 3% organic growth in 2025, alongside double-digit EPS increases and robust cash flows as reported in third-quarter 2025 results.^[85][63] The restructurings also mitigated risks from PFAS litigation settlements, enhancing long-term financial resilience despite short-term adjustments.^[86]

Global Presence and Facilities

Manufacturing and Operational Sites

3M operates over 100 manufacturing facilities worldwide, supporting its production of diversified products across safety, industrial, transportation, electronics, health care, and consumer segments.^[42] The company's global headquarters, known as 3M Center, is located in Maplewood, Minnesota, adjacent to St. Paul, functioning as a central hub for executive operations, research and development, and administrative functions.^[87] In the United States, 3M maintains manufacturing sites across multiple states, including Alabama (Decatur and Guin), Illinois (Cordova and DeKalb), Minnesota (Alexandria, Cottage Grove, Fairmont, Hutchinson, and New Ulm), Ohio (Medina), South Carolina (Greenville), Arkansas (Little Rock), and Nevada.^[88] The Decatur, Alabama facility, established in 1961, comprises two distinct plants dedicated to films and materials production.^[89] In 2022, 3M committed approximately $470 million to expand its Clinton, Tennessee plant, with plans to create around 600 jobs by 2025 to enhance output of Filtrete air filters and Command adhesive strips.^[90][91] Internationally, 3M's operational footprint spans more than 70 countries, with key manufacturing sites including Itapetininga, Brazil, where a plastic recycling line was introduced in 2024; Villach, Austria, featuring energy repurposing initiatives; and Ranjangaon, India, with ongoing water conservation efforts.^[42] These facilities contribute to localized production, supply chain efficiency, and sustainability goals, such as evaluating water risk across all sites using tools like the Aqueduct Water Risk Atlas.^[42]

International Expansion and Workforce

3M initiated its international expansion in the post-World War II era, establishing an International Division in 1951 to oversee operations abroad. This led to the creation of subsidiaries in key markets including Australia, Brazil, Canada, France, Germany, Mexico, and the United Kingdom, marking the company's shift from a primarily U.S.-focused manufacturer to a global enterprise. By the 1960s, 3M had extended its footprint into additional European and Latin American countries, leveraging its diversified product lines in abrasives, adhesives, and tapes to penetrate industrial and consumer markets.^[1] A pivotal milestone occurred in 1984 when 3M became the first wholly foreign-owned enterprise in the People's Republic of China, establishing a manufacturing presence in Hubei Province that facilitated entry into Asia's burgeoning markets. Subsequent expansions included significant investments in Southeast Asia, such as factory upgrades in Singapore's Woodlands in 2011 and a major Tuas plant expansion announced in 2016, alongside new regional headquarters there. These moves supported growth in electronics and display technologies, aligning with global supply chain demands. By the early 2010s, international operations generated approximately 60% of 3M's total revenue, with projections aiming for two-thirds by 2017 through organic growth and targeted acquisitions.^[11][92] As of 2024, 3M maintains manufacturing and sales operations in more than 70 countries, with products distributed to over 200 nations, reflecting a strategy emphasizing localized production to mitigate tariffs and currency risks while capitalizing on regional demand in safety, industrial, and consumer segments. The company's global network includes subsidiaries tailored to specific markets, such as 3M Japan Holdings and 3M Italia, underscoring adaptations to local regulations and consumer preferences. This expansion has been bolstered by over 60 acquisitions since the 2000s, many enhancing international capabilities in filtration, electronics, and healthcare-related technologies prior to the 2024 Solventum spin-off.^[93][94] 3M's global workforce stood at approximately 61,500 employees as of December 31, 2024, a reduction from 85,000 in 2023 primarily attributable to the divestiture of its Health Care business into Solventum Inc. earlier that year. While detailed regional breakdowns are not publicly itemized in recent filings, historical data indicate a U.S.-centric employee base supplemented by substantial international staffing, with Europe, Middle East, and Africa (EMEA) alone employing around 20,000-25,000 in prior years before adjustments. The company's human resources strategy emphasizes competitive compensation, innovation incentives, and diversity in technical roles to support R&D across borders, though recent restructurings have focused on cost efficiencies amid economic pressures.^[95][96][42]

Leadership and Governance

Historical and Current Executives

3M was founded in 1902 as Minnesota Mining and Manufacturing Company by five partners, with early leadership focused on mineral extraction before pivoting to abrasives and adhesives. William L. McKnight, who joined in 1907 as an assistant bookkeeper, rose to become the company's president in 1929 and chairman, guiding 3M through diversification into products like Scotch Tape and establishing a culture emphasizing innovation and employee initiative until his retirement in 1966.^[11] Following McKnight, Bert S. Cross served as president and CEO from 1966 to 1970, overseeing international expansion amid antitrust challenges. Harry Heltzer held the role from 1970 to 1975, emphasizing sales growth through new product lines such as surgical drapes. Raymond H. Herzog acted as president from 1970 to 1975 and then chairman and CEO until 1979, prioritizing early pollution control measures during economic pressures. Lewis W. Lehr led as CEO from 1979 to 1986, focusing on consumer office products including the development of Post-it Notes. Allen F. Jacobson served from 1986 to 1991, driving U.S. market innovations but facing international growth slowdowns. Livio DeSimone was CEO from 1991 to 2001, accelerating global revenue and R&D investments. James McNerney, from 2001 to 2005, implemented productivity initiatives like "3M Acceleration" to streamline operations. George W. Buckley led from 2005 to 2012, rebuilding R&D pipelines amid rising costs. Inge G. Thulin served as CEO from 2012 to 2018, restoring revenue through increased R&D spending while navigating stock volatility. Michael F. Roman became CEO in 2018, directing cost reductions and portfolio simplification until transitioning in 2024.^[97] As of October 2025, William M. (Bill) Brown serves as 3M's chairman and chief executive officer, having been appointed CEO effective May 1, 2024, and chairman effective March 1, 2025, succeeding Roman who remains executive chairman.^[98][99] Key current executives include John Banovetz, executive vice president and chief technology officer; Anurag Maheshwari, executive vice president and chief financial officer; and Bryan C. Hanson, group president and CEO of the healthcare business.^[100][101] The leadership team reports to Brown and oversees 3M's operations across safety, industrial, transportation, healthcare, and consumer segments, with a focus on innovation, supply chain resilience, and resolution of legacy liabilities.^[102]

Corporate Culture and Management Practices

3M's corporate culture emphasizes innovation through employee autonomy, exemplified by the "15% rule" established around 1948, which permits technical staff to allocate up to 15% of their work time to self-directed projects aligned with business goals.^[45][103] This practice has fostered breakthroughs such as the Post-it Note, developed by chemist Spencer Silver and marketed by Art Fry in the 1970s using company resources for personal experimentation.^[104] The policy reflects a broader philosophy prioritizing long-term creativity over short-term metrics, with tolerance for failure and minimal bureaucratic oversight to encourage risk-taking.^[105] Management practices at 3M promote decentralization and employee support, structured around three core principles: relentless innovation, strategic diversification across industries, and investment in workforce development.^[106] This includes a tiered reporting system that balances direct oversight with empowerment, allowing cross-functional collaboration and access to internal resources for idea prototyping.^[107] Leadership adopts a transformational style, blending democratic decision-making with systematic processes to sustain agility, as evidenced by employee surveys highlighting innovation and adaptability as dominant cultural values.^[108][109] Tensions arose in the early 2000s when 3M adopted Six Sigma methodologies under CEO James McNerney to enhance efficiency, which clashed with the existing culture of unstructured experimentation by imposing standardization and reducing tolerance for variance.^[105] Subsequent leaders relaxed these constraints to preserve innovative ethos, underscoring a causal link between cultural flexibility and sustained product development.^[46] Overall, 3M's approach integrates employee initiative with governance frameworks that delegate operational authority to executives while maintaining board-level oversight on ethical and strategic alignment.^[110]

Careers and Talent Development

3M organizes the annual RISE Symposium (Raising Influence in Science and Engineering), a virtual multi-day conference that introduces emerging doctoral students in science and engineering to rewarding careers in research and development at 3M. The program includes professional development sessions, networking with 3M researchers and executives, insights into the recruiting process, and exposure to innovation. It is open to students of all backgrounds on a merit basis, with a focus on underrepresented groups in STEM, particularly those nearing completion of their PhD (typically within 24 months of the event). Applications require a resume and research statement, with deadlines often in early May for summer events (e.g., May 1 for the 2026 edition held August 17–19).

Innovations and Societal Contributions

Breakthrough Products and Technologies

3M's breakthroughs in products and technologies originated from its early focus on abrasives and evolved into adhesives, protective coatings, and advanced materials, often arising from serendipitous discoveries within its research labs. The company's "15% rule," allowing employees to dedicate time to personal projects, facilitated innovations like repositionable adhesives and fluorochemical repellents. These developments have influenced industries from automotive manufacturing to consumer goods, with over 60,000 products derived from core platforms such as surface modification and adhesive technologies.^[11][1] In abrasives, 3M introduced the world's first water-resistant coated abrasive, 3M™ Wetordry™ Waterproof Sandpaper, in 1921, which minimized dust and friction during wet sanding for automobile body work. This was followed by 3M™ Three-M-Ite™ Abrasive Cloth in 1914, an early commercial success that established 3M's expertise in mineral-based grinding materials. More recently, in 2009, 3M™ Cubitron™ II Fibre Discs employed patented precision-shaped ceramic grains, extending abrasive life up to four times compared to traditional products and reducing grinding costs in metalworking.^[11][1][11] Adhesive innovations defined 3M's consumer impact, starting with Scotch® Masking Tape in 1925, invented by Richard G. Drew to prevent paint bleed during automotive refinishing, and Scotch® Cellophane Tape in 1930, which provided a transparent, pressure-sensitive sealing solution amid the Great Depression's demand for mending materials. The Post-it® Note, launched in 1980 after test marketing, stemmed from Spencer Silver's 1968 discovery of a low-tack, reusable adhesive during attempts to create stronger bonds; Art Fry adapted it for non-damaging bookmarks in hymnals, creating a new category for temporary labeling and reminders.^{[11][111][11]} Protective and optical technologies included 3M™ Scotchlite™ Reflective Sheeting in 1938, utilizing glass microspheres for retroreflection to enhance nighttime visibility on traffic signs, first deployed in Minneapolis in 1939 and later adopted for highways worldwide. Scotchgard™ Fabric Protector, commercialized in 1956, originated from a 1952 laboratory accident where Patsy Sherman and Samuel Smith observed a fluorochemical compound repelling water and stains on footwear, leading to its application in textiles and upholstery. In healthcare, 3M™ Micropore™ Surgical Tape in 1960 marked the first hypoallergenic adhesive tape, enabling skin-friendly wound care and expanding 3M's medical portfolio. Thermal insulation advanced with 3M™ Thinsulate™ in 1979, featuring microfiber structures that trapped air more efficiently than down or polyester, quickly adopted by apparel manufacturers for cold-weather gear.^[11][112][1]

Economic Impact and Job Creation

3M employs approximately 61,500 people globally as of December 31, 2024, including 22,500 in the United States, providing direct jobs in manufacturing, research, and administrative roles across its core segments of Safety and Industrial, Transportation and Electronics, and Consumer. This workforce supports economic activity through wages, benefits, and local spending, particularly in Minnesota, where the company's headquarters in Maplewood anchors regional employment despite challenges from economic slowdowns. The employee count reflects a decline from 85,000 in 2023, primarily due to the April 2024 spin-off of the Health Care business into Solventum and a 2023-2025 restructuring that eliminated about 8,000 positions to streamline operations and reduce costs amid decelerating demand.^[40][42] The company's 2024 net sales of $24.6 billion underpin broader economic contributions via a supply chain encompassing nearly 30,600 suppliers in 91 countries, with annual cost of goods expenditures around $13 billion, much of which flows to procurement and logistics partners. Investments of $1.1 billion in research and development—equivalent to 4.4% of sales—and $1.2 billion in capital expenditures further amplify impact by driving technological advancements and facility upgrades that sustain high-skill jobs in innovation hubs. In Minnesota, 3M's operations have historically stabilized local employment, as seen in facilities like New Ulm where headcount rebounded to about 1,100 by mid-2025 after earlier dips, while initiatives such as the Manufacturing Advocacy Partnership equip students for skilled trades to address manufacturing talent gaps.^{[40][42][113]} 3M has directed $50 million toward workforce development since 2020, funding programs in STEM and vocational training to foster future job creation, alongside cumulative community investments exceeding $2.1 billion since 1953 that indirectly bolster economic resilience. These efforts align with restructuring under new leadership to prioritize efficiency and growth in high-potential areas, positioning the company to generate sustained employment in advanced materials and industrial applications despite short-term contractions.^[42][114]

Role in Public Health and Industry Standards

3M has played a significant role in public health through its development and supply of personal protective equipment (PPE), particularly N95 respirators certified by the National Institute for Occupational Safety and Health (NIOSH) to filter at least 95% of airborne particles.^[115] These respirators have been essential for healthcare workers combating respiratory pathogens, including during the COVID-19 pandemic, where 3M entered agreements with the U.S. government to facilitate the importation and distribution of over 228 million units between April and September 2020.^[116] Additionally, 3M donated thousands of powered air-purifying respirators to organizations like Direct Relief for frontline medical use.^[117] In infection prevention, 3M offers FDA-cleared products such as the Tegaderm CHG Chlorhexidine Gluconate I.V. Securement Dressing, approved under 510(k) K153410 in 2015 for reducing catheter-related bloodstream infections, and the Steri-Drape CI-G Antimicrobial Incise Drape, cleared in 2014 for continuous antimicrobial activity at incision sites.^[118][119] Surgical solutions like DuraPrep, approved via New Drug Application in 2006, provide persistent antimicrobial action, marking one of the early FDA-recognized innovations in preoperative skin preparation.^[120] Regarding industry standards, 3M's PPE portfolio aligns with and supports key benchmarks from organizations like the American National Standards Institute (ANSI), American Society for Testing and Materials (ASTM), and Occupational Safety and Health Administration (OSHA), including updates where OSHA incorporates consensus standards for eye, face, head, and respiratory protection.^[121][122] Products such as surgical N95 respirators also meet FDA requirements for fluid resistance and biocompatibility, contributing to standardized protocols in healthcare and manufacturing environments. 3M maintains ISO 9001 certification for quality management, ensuring consistent compliance across global operations for safety equipment used in sectors like pharmaceuticals and chemicals.^[123]

Legal and Environmental Challenges

PFAS Chemicals and Water Contamination

3M began producing per- and polyfluoroalkyl substances (PFAS), including perfluorooctane sulfonate (PFOS) and perfluorooctanoic acid (PFOA), in the 1950s for applications such as water- and stain-resistant coatings in products like Scotchgard.^[124] Internal studies by 3M as early as the 1950s demonstrated that these chemicals could accumulate in blood and persist in the environment, yet production continued for decades.^[125] In 2000, following detection of elevated PFOS levels in the blood of employees, their families, and the general population, 3M voluntarily notified the U.S. Environmental Protection Agency (EPA) and announced a phase-out of PFOS manufacturing, completing it by 2002; PFOA production was similarly phased out around the same period.^[126] This action preceded broader industry commitments, such as the 2006 EPA stewardship program with other manufacturers to reduce PFOA emissions and product content by 95% by 2010 and eliminate long-chain PFAS by 2015.^[127] PFAS contamination from 3M facilities has affected groundwater, surface water, and drinking supplies near multiple sites, driven by the chemicals' resistance to degradation—earning them the designation "forever chemicals" due to half-lives exceeding decades in the environment and human body.^[128] In Minnesota's East Metro area, encompassing sites like Cottage Grove, Woodbury, and Oakdale, investigations revealed widespread pollution spanning approximately 150 square miles around 3M's headquarters, with PFOS and related compounds detected in local fish, private wells, and municipal systems; the Minnesota Pollution Control Agency oversees remediation at these locations.^[129] Similar issues occurred at the 3M Decatur, Alabama plant, contaminating the Tennessee River; the Cordova, Illinois facility, where EPA-ordered sampling in private wells detected PFOA concentrations up to thousands of parts per trillion; and New Jersey's Chambers Works and Parlin sites, linked to statewide environmental releases.^[130][131] These persistences stem from historical discharges, including wastewater and landfill leachate, with bioaccumulation observed in wildlife and human blood samples near facilities.^[132] Regulatory responses intensified post-phase-out, with the EPA issuing stricter health advisories in 2022 setting effectively zero safe levels for PFOA and PFOS in drinking water, followed by 2024 national primary drinking water standards mandating monitoring and treatment for six PFAS compounds.^[133][134] 3M committed in December 2022 to fully exit PFAS manufacturing and use by the end of 2025, citing annual sales of about $1 billion from such products at the time.^[135] Litigation has resulted in major settlements addressing water contamination. In June 2023, 3M agreed to pay up to $10.3 billion over 13 years to over 6,000 U.S. public water systems for PFAS testing and remediation, with the U.S. District Court approving the deal in March 2024; funds are allocated based on detected levels exceeding EPA limits.^[136] In May 2025, New Jersey secured a $450 million settlement from 3M for statewide PFAS impacts, including $43.45 million initial payment for natural resource damages at Chambers Works and abatement projects.^[137] These agreements do not admit liability but provide resources for cleanup, amid ongoing individual and class-action suits alleging health risks like cancer and immune effects, though causal links remain under scientific scrutiny with varying evidence from epidemiological studies.^[138]

Product Liability Cases

3M has encountered multiple product liability lawsuits alleging defects in its personal protective and medical equipment, with the most prominent involving its Combat Arms earplugs and Bair Hugger patient warming systems. These cases center on claims of design flaws, inadequate testing, and failure to warn, leading to personal injuries such as hearing damage and surgical infections. While 3M has consistently denied wrongdoing in these matters, asserting that its products met applicable standards and that scientific evidence supports their safety, the company has entered settlements to resolve litigation and avoid protracted trials.^[139][140] The Combat Arms Earplugs litigation, consolidated as Multidistrict Litigation (MDL) No. 2885 in the U.S. District Court for the Northern District of Florida, involved over 250,000 claims from U.S. military service members and veterans. Plaintiffs alleged that the dual-ended foam earplugs, supplied to the Department of Defense from 2003 to 2015 under contracts worth approximately $9 million, were defectively designed and manufactured, failing to provide adequate noise protection when the dual ends were not properly inserted, resulting in hearing loss and tinnitus. Internal documents revealed that 3M and its subsidiary Aearo Technologies knew of testing deficiencies as early as 2000 but continued sales without disclosure or redesign. Several bellwether trials resulted in multimillion-dollar verdicts against 3M, including a $110 million award in 2021 later reduced, though some were appealed or overturned. In August 2023, 3M agreed to a $6.01 billion settlement to resolve all claims, with payments structured in installments from 2023 to 2029 contingent on claimant participation thresholds; the deal did not include an admission of liability.^{[141][6][139][142]} In the Bair Hugger cases, part of MDL No. 3017 in the U.S. District Court for the District of Minnesota, patients claimed that 3M's forced-air warming blankets, used during orthopedic surgeries like hip and knee replacements since the 1980s, redistributed airborne bacteria into sterile surgical fields, causing deep joint infections requiring revision surgeries or amputations. Over 7,600 lawsuits were pending as of late 2024, with plaintiffs citing studies suggesting increased infection risks from the system's airflow mechanism. 3M countered with peer-reviewed research and FDA clearances affirming the device's efficacy in preventing hypothermia without elevating infection rates, attributing claims to unrelated factors. Key trial outcomes included a $16.2 million verdict for plaintiffs in 2022, reversed on appeal, and a Minnesota appellate court affirming summary judgment for 3M in dozens of cases in 2021 based on insufficient causation evidence. No global settlement has been reached, and litigation continues with 3M maintaining the product's safety profile supported by clinical data.^{[143][144][140][145]} Other product liability actions against 3M have included claims over defective respirators and dust masks, alleging inadequate filtration leading to exposure risks, though these have not resulted in settlements on the scale of the earplugs or Bair Hugger cases. For instance, a class action accused 3M of selling flawed respirators despite known defects, but outcomes remain limited without major payouts reported. These disputes underscore ongoing scrutiny of 3M's quality control in safety-critical products, balanced against the company's defense that rigorous testing and regulatory approvals mitigate liability risks.^[146]

Regulatory Compliance and Penalties

In August 2023, the U.S. Securities and Exchange Commission charged 3M with violations of the Foreign Corrupt Practices Act's books and records and internal controls provisions stemming from inadequate oversight of third-party intermediaries in Russia and China, leading to a settlement requiring payment of more than $6.5 million in disgorgement, interest, and penalties.^[147] The SEC determined that 3M failed to maintain sufficient internal accounting controls and accurate books for certain payments, though no bribery charges were brought.^[147] In September 2023, the U.S. Department of the Treasury's Office of Foreign Assets Control settled with 3M for $9,618,477 over 54 apparent violations of Iranian sanctions regulations occurring between 2016 and 2018, involving exports of U.S.-origin goods through third-party distributors without required authorizations.^[148] OFAC noted that the violations were non-egregious and self-reported in part, with 3M having implemented remedial measures including enhanced compliance training and transaction screening.^[148] Separately, in July 2025, the U.S. Environmental Protection Agency settled with 3M for $1,521,481 in civil penalties across 244 counts of failing to report data under the Toxic Substances Control Act, following an audit that prompted corrections to the company's reporting processes.^[149] 3M has also faced penalties for workplace safety violations under the Occupational Safety and Health Administration. In November 2023, OSHA cited the company for two willful violations after a worker's fatal entanglement in a plastic extrusion machine at its Prairie du Chien, Wisconsin facility, proposing $312,518 in penalties for inadequate machine guarding and failure to prevent hazardous energy exposure during servicing.^[150] In October 2024, the EPA additionally required 3M to pay $125,900 for hazardous waste storage violations at a Cordova, Illinois site, including improper container labeling and segregation that posed risks to workers.^[151] These incidents reflect ongoing scrutiny of 3M's operational compliance, though the company has contested some citations and invested in safety enhancements.^[150]